Genomtec (WAR:GMT) FCF Margin % : 0.00% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Genomtec FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Genomtec's Free Cash Flow for the three months ended in Sep. 2024 was zł-7.33 Mil. Genomtec's Revenue for the three months ended in Sep. 2024 was zł0.00 Mil. Therefore, Genomtec's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

As of today, Genomtec's current FCF Yield % is -8.87%.

The historical rank and industry rank for Genomtec's FCF Margin % or its related term are showing as below:

WAR:GMT' s FCF Margin % Range Over the Past 10 Years
Min: -1147900 Med: -13135 Max: -2096.08
Current: -974300

During the past 6 years, the highest FCF Margin % of Genomtec was -2096.08%. The lowest was -1147900.00%. And the median was -13135.00%.

WAR:GMT's FCF Margin % is ranked worse than
99.88% of 820 companies
in the Medical Devices & Instruments industry
Industry Median: -3.58 vs WAR:GMT: -974300.00

Genomtec FCF Margin % Historical Data

The historical data trend for Genomtec's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomtec FCF Margin % Chart

Genomtec Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-2,096.08

-13,135.00

-2,608.68

-19,822.50

-1,147,900.00

Genomtec Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial														-320,200.00	-	1,038.72	1,166.04	-

Competitive Comparison of Genomtec's FCF Margin %

For the Medical Devices subindustry, Genomtec's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genomtec's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Genomtec's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Genomtec's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Genomtec FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Genomtec's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-11.479	/	0.001
	=	-1,147,900.00 %

Genomtec's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-7.328	/	0
	=	%

Genomtec FCF Margin % Related Terms

Thank you for viewing the detailed overview of Genomtec's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomtec Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Genomtec SA (WAR:GMT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

4VI:Germany

Address

ul. Stab?owicka 147, PORT Building 2, Wroclaw, POL, 54-066

Website

http://www.genomtec.com

Genomtec SA is an innovative technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.

Genomtec Headlines

No Headlines